From patient samples to clinically relevant biomarkers
Turn complex patient samples into actionable biological insights with clinical proteomics. Evotec combines more than 20 years of mass spectrometry-based proteomics expertise with high-throughput technologies, advanced bioinformatics and integrated biomarker validation to support biomarker development from discovery through clinical application.
Our industrialized ScreenPep proteomics platform enables robust, high-throughput profiling of solid and liquid biopsies from large patient cohorts, helping pharmaceutical and biotech companies accelerate precision medicine programs.
Why choose Evotec for clinical proteomics?
- 20+ years of mass spectrometry-based proteomics experience
- >100 proteomics experts and scientists
- >40 state-of-the-art mass spectrometers
- >5 PB of raw data generated annually
- >30,000 clinical samples processed per year per MS instrument
- High-throughput, automated clinical proteomics using ScreenPep™
- Integrated biomarker discovery, validation and data analysis
- Multiomics integration supported by PanHunter®
